Navigation Links
Human Genome Sciences Announces Fourth-Quarter and Full-Year 2008 Financial Results and Key Developments
Date:2/26/2009

riability in the timing of cost-sharing reimbursements related to HGS products in Phase 3 development. (For information on the calculation of this non-GAAP financial measure, visit www.hgsi.com/images/Q42008results/netcashburn.pdf.) In financial guidance provided in January 2009, HGS indicated an expected net cash burn for full-year 2009 of less than $25 million.

As of December 31, 2008, cash and investments totaled $372.9 million, of which $294.2 million was unrestricted and available for operations. This compares with cash and investments totaling $603.8 million as of the end of December 31, 2007, of which $532.9 million was unrestricted and available for operations.

For the fourth quarter ended December 31, 2008, HGS reported revenues of $12.9 million, compared with revenues of $12.5 million for the same period in 2007. Fourth quarter 2008 revenues included $8.9 million recognized from the Albuferon agreement with Novartis, and $1.6 million recognized from the LymphoStat-B agreement with GSK.

The Company's net loss in the fourth quarter of 2008 was $55.7 million ($0.41 per share), compared with a net loss of $92.9 million ($0.69 per share) in the fourth quarter of 2007. The decrease was due primarily to reduced clinical development spending related to the winding down of Albuferon Phase 3 trials. In addition, the fourth quarter 2007 net loss included $16.9 million ($0.13 per share) in expenses related to the licensing and collaboration agreement entered into with Aegera Therapeutics.

HIGHLIGHTS OF RECENT PRODUCT PROGRESS

ABthrax(TM): At Least $150 Million Expected for Delivery to Stockpile

In January 2009, HGS began delivery of 20,000 doses of ABthrax (raxibacumab) to the U.S. Strategic National Stockpile for emergency use in the treatment of inhalation anth
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. IlluminOss Medical Announces First Human Case Utilizing a Unique, New, Minimally Invasive Technology for Fracture Repair is Performed at Medical Hospital del Trabajadar in Santiago, Chile
2. GeoVax Starts Injections for Phase 2a Human HIV/AIDS Vaccine Trial in USA
3. FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
4. Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs
5. Human Genome Sciences Begins Delivery of First-in-Class Anthrax Treatment to U.S. Strategic National Stockpile
6. Mardil Inc. Advances Its Novel Cardiac Device to First-In-Human Trials for Mitral Valve Regurgitation
7. Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
8. Human Genome Sciences Reports Substantial Progress Toward Commercialization and Announces 2009 Goals at JPMorgan Healthcare Conference
9. Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference
10. 2008 Human Research Protection Award Recipients Announced
11. USD 12.5 m Funding for the Development of Intercells Vaccine Patch System for Pandemic Influenza From U.S. Department of Health and Human Services (HHS)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... , May 29, 2015 A six-hour certification program ... being presented at the Cannabis World Congress & Business ... New York, NY .  Taking place on Wednesday, June ... day of education at the leading event on the East ... Led by Clover Leaf University, the first cannabis university ...
(Date:5/29/2015)... , May 29, 2015  Dr. Yair Walzer ... to resolve vaginal health issues often caused by menopause. The ... requires no anesthesia, received FDA clearance in 2014. Dr. Walzer ... to offer the special fractional CO 2 ... breast cancer survivors. In 2010 there were ...
(Date:5/29/2015)... 29, 2015  The annual customer satisfaction survey of ... EMR as #1 across all specialties. Every year, ... conducts a poll of EHR users and publishes an ... Praxis EMR topped 348 other systems, ... based criteria used by Black Book. In addition to ...
Breaking Medicine Technology:Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 2Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 3Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 4The Newest FDA-Cleared Breakthrough In Women's Health Treatments 2Praxis EMR Ranks #1 for Physician Satisfaction in Black Book's 2015 Survey of Solo and Small Practices 2
... Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and ... of a new education campaign designed to help answer ... a reference tool to supplement their discussions about vaccination ... provides consumer-friendly, accurate and science-based information about immunization that ...
... DEERFIELD, Ill., Nov. 17, 2011 Today, Takeda ... (dexlansoprazole) product labeling now includes information from a ... no clinically important effect on exposure to the ... No dose adjustment of clopidogrel is necessary when ...
Cached Medicine Technology:Sanofi Pasteur Launches Nationwide Education Campaign to Help Parents Make Informed Decisions about Immunization 2Sanofi Pasteur Launches Nationwide Education Campaign to Help Parents Make Informed Decisions about Immunization 3Sanofi Pasteur Launches Nationwide Education Campaign to Help Parents Make Informed Decisions about Immunization 4DEXILANT (dexlansoprazole) Product Information Updated Regarding Coadministration with Plavix (clopidogrel bisulfate) 2DEXILANT (dexlansoprazole) Product Information Updated Regarding Coadministration with Plavix (clopidogrel bisulfate) 3DEXILANT (dexlansoprazole) Product Information Updated Regarding Coadministration with Plavix (clopidogrel bisulfate) 4DEXILANT (dexlansoprazole) Product Information Updated Regarding Coadministration with Plavix (clopidogrel bisulfate) 5
(Date:5/29/2015)... To compile the list, the Becker's ... have several awards for clinical and general excellence. The ... out to them in terms of overall excellence, and ... The 50 Great Health Systems to Know 2015 list ... Springs, Fla.) , Advocate Health Care (Downers Grove, Ill.) ...
(Date:5/29/2015)... May 29, 2015 The Healthcare ... graduates of its Advanced Training Program (ATP) in ... fill roles in their health care organization ranging ... and methodology of continuous quality improvement in the ... to Dr. Brent James’ internationally recognized Advanced Training ...
(Date:5/29/2015)... New York (PRWEB) May 29, 2015 ... of patented products, announces that it has signed a ... a technology patent that aims to let people learn ... experts in real time. , "This is an exciting ... Room " said Scott J. Cooper, CEO and Creative ...
(Date:5/29/2015)... Inspire Nexus, a new social network officially launching ... many life coaches have asked, "How do I find ... to become a credentialed Coach?" , Many Life and ... long. Inspire Nexus, a social network for Coaches provides ... have experience coaching a certain number of hours, qualify ...
(Date:5/29/2015)... May 29, 2015 Mediaplanet has joined ... educate readers on the importance of proper sun protection. ... USA Today, with a circulation of approximately 250,000 copies ... component is distributed nationally, through a vast social media ... and partner outlets. To explore the digital version of ...
Breaking Medicine News(10 mins):Health News:Becker's Hospital Review Names 50 Great Health Systems to Know 2Health News:Becker's Hospital Review Names 50 Great Health Systems to Know 3Health News:HORNE LLP’s Healthcare Delivery Institute Graduates Class from the Advanced Training Program 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 4Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 5
... of long-term use still outweigh possible benefits , SUNDAY, ... seemed like a wonderful means to help women age ... as their bodies began to produce decreased amounts of ... heart disease, osteoporosis and cancer. , But those beliefs ...
... the annual meeting of the American Sociological Association. Below are ... COUNTRY Gay depictions in the media have "exploded" in ... youth still find it difficult to find people like them on ... to help them come to terms with their sexual identity and ...
... undergoes surgery, follow these helpful tips , SATURDAY, Aug. 8 ... undergoing surgery, it helps if parents and children are well-prepared, ... can be a source of stress for a person of ... whole new layer of sensitivity is added," ASA President Dr. ...
... health-care system perspective, it may be more efficient to use ... have a wild-type KRAS gene, according to a study published ... Cancer Institute . Earlier, patients whose tumors harbored wild-type ... treated with cetuximab in a randomized trial by the National ...
... , , Provides Protection for People with ... WASHINGTON, Aug. 7 The Lupus Foundation of America (LFA) President ... regarding S.1630 "The Affordable Access to Prescription Medications Act of ... (Jay) D. Rockefeller IV (D-WV). , , ...
... , , MORRISTOWN, N.J., ... a leading specialty pharmaceutical company, announced today that one lot of ... is being voluntarily recalled from wholesalers and pharmacies. The recalled ... 2011 and were manufactured by Watson Laboratories, Inc. and distributed by ...
Cached Medicine News:Health News:In U.S., No Comeback Seen for Hormone Therapy 2Health News:In U.S., No Comeback Seen for Hormone Therapy 3Health News:Indiana University research at the American Sociological Association annual meeting 2Health News:Indiana University research at the American Sociological Association annual meeting 3Health News:Indiana University research at the American Sociological Association annual meeting 4Health News:Good Planning Paves Way for Kid's Operation 2Health News:Cost-effectiveness of cetuximab in metastatic colorectal cancer 2Health News:The Lupus Foundation of America Applauds New Legislation that Caps Out-of-Pocket Drug Costs 2Health News:Watson Announces Limited Recall Of Fentanyl Transdermal System 2Health News:Watson Announces Limited Recall Of Fentanyl Transdermal System 3
... assay is an immunometric ('sandwich') EIA ... in human serum or plasma. LH ... 2 monoclonal anti-LH antibodies directed at ... to magnetic particles and the other ...
... Luteinizing hormone (LH) is a glycoprotein ... the FSH, hCG and TSH, the intact ... alpha- and beta-subunits. These glycoproteins all have ... unique beta-subunit. Both LH and FSH production ...
... StreamLAB combines consolidated ... Systems with pre- and ... an innovative laboratory automation ... needs of today's laboratories, ...
... simplifies and enhances critical care ... features such as its self-contained ... options, the GEM Premier 3000 ... (iQM), an internal, automated program ...
Medicine Products: